OCM for Euro Virology Series Conferences

Organizing Committee

Biography

Giulio Filippo Tarro has graduated from Medicine School, Naples University (1962). He was a Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. He was an Oncological Virology Professor, Naples University (1972-1985). Since 2007, he was the Chairman of Committee of Biotechnologies, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization Lifetime Achievement Award (2010). He is the President Foundation de Beaumont Bonelli for Cancer Research

Research Interest

Murine Virology,Antiviral Chemotherapy,
Effects of inhibitors on viraI replication,
Studies on the role of herpesviruses in cancer,
Tumor immunology,Pathology of AIDS

Biography

Min-Hua Luo, M.D. & Ph.D., professor at Wuhan Institute of Virology, State Key Laboratory of Virology and CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT); affiliate assistant professor, University of Idaho. Dr. Luo received her BSc in Clinical Medicine in 1988; MSc in Microbiology in 1995 from Hunan Medical University; Ph.D. in Infectious Diseases in 1999, collaborate with Innsbruck University, Austria; Postdoct training in Shriver Center, Harvard Medical School in 2002; Research Scientist at Dept. MMBB, University of Idaho in 2004; Assistant professor at Dept. MMBB, University of Idaho in 2008; professor at Wuhan Institute of Virology, CAS in 2009; professor at CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) in 2014. Her research has focused on NEUROVIROLOGY and supported by funding resources of NSFC, NIH. "Hundred Talents" program from CAS, and "973" program from MOST.

Research Interest

Biography

Dr. Bukrinsky obtained medical degree (M.D.) from the 2nd Moscow State Medical Institute in Moscow, Russia, and a doctorate (Ph.D.) in Molecular Biology from the Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. Currently Dr. Bukrinsky is Professor of Microbiology, Immunology and Tropical Medicine at the George Washington University School of Medicine and Health Sciences. He is a Fellow of the American Heart Association, the Editor-in-Chief of the Open AIDS Journal, and member of the Editorial Advisory Board of several biomedical journals. Dr. Bukrinsky’s research interests are in molecular mechanisms governing HIV replication and pathogenesis. His latest research focuses on changes in cholesterol metabolism induced by HIV and its protein Nef. Dr. Bukrinsky has published over 150 scientific papers, reviews and book chapters and is an inventor on 12 issued U.S patents.

Research Interest

HIV lifecycle, the mechanisms of HIV replication in host cells and the mechanisms of HIV pathogenesis and its effects on different tissues and organs, HIV-antigen-based diagnostic system

Biography

Zajac V has completed his PhD in 1982 from the Cancer Research Institute of Slovak Academy of Sciences in Bratislava (Slovakia), where he worked as the Head of Department of Cancer Genetics from 1996 to 2010. He joined the Medical Faculty of the Comenius University as an Associate Professor of Genetics in 2007. He has published 69 papers mostly in reputed journals and he was editor of the book “Bacteria, viruses and parasites in AIDS process” (InTech, 2011).

Research Interest

Biography

Dr. Marco Ciotti has received his Medicine Degree in “La Sapienza” University of Rome in 1989; an Oncology degree at the University of Rome “Tor Vergata” in 1994, and a degree in Microbiology and Virology in 2001 in the same University. Since 2002, he works as Microbiologist at the University Hospital Tor Vergata, Rome, Italy. His main field of interests are HPV and cervical carcinogenesis, pathogenetic role of human polyomaviruses in immunocompromised patients, and diagnosis and molecular characterization of hepatitis viruses. He is serving as an editorial member of several reputed journals. He authored several research articles, one book, and chapters of books. He is a member of the Italian Society of Microbiology.

Research Interest

Biography

Ronald Moss, M.D. has served as the Chief Executive Officer of Ansun Biopharma, Inc. since October 2012, and before that, served as both interim CEO and Executive Vice President of Clinical Development and Medical Affairs at Ansun from 2008 to 2012. Dr. Moss has held various executive positions in the pharmaceutical industry for over 20 years and has played a pivotal role in successfully leading companies through the complexities of drug and vaccine development. Dr. Moss has been involved in drug and vaccine development of products in Infectious Disease, Allergy, Neurology, Dermatology, Oncology, Respiratory, Transplant, and Autoimmunity in both large pharmaceutical and biotechnology companies, including roles at Aventis, Immune Response, Merck, Telos and Vical. He has also authored over 70 scientific publications. Prior to joining industry, he received his M.D. degree from Chicago Medical School, completed a residency in pediatrics at SUNY Stony Brook and completed a fellowship at the National Institutes of Health. He is double boarded in Pediatrics and Allergy and Immunology. He is also a Fellow of the American Academy and American College of Allergy and Immunology

Research Interest

Biography

Professor Ting-Chao Chou received MS degree in Pharmacology from National Taiwan University College of Medicine; Ph.D. from Yale University, and Postdoctoral Fellowship at Johns Hopkins University School of Medicine. Joined Memorial Sloan-Kettering Cancer Center (MSKCC), became Member 1988-96, and a Professor of Pharmacology at Cornell University Graduate School of Medical Sciences, 1988-2000. He is Honorary Professor at Chinese Academy of Medical Sciences, Beijing and five other universities. He focused in the new drug discovery as the Director of Preclinical Pharmacology Core at MSKCC, where he retired on June1, 2013. His 273 scientific articles have been cited by 15,606 papers (as of 8.31.2014). (Thomson Reuters Web of Science: www.researcherid.com/rid/B-4111-2009). Prof. Chou introduced the “Unified Theory of the Median-Effect Equation of the Mass-Action Law”, and with Prof. Paul Talalay (JHU) in 1984, created the “Combination Index Theorem” for multiple entity dynamics. For one article alone (Chou TC and Talalay P., Adv Enz Regul 22:27-55, 1984), cited by 3,218 articles published in 599 biomedical journals and has become one of four the most broadly cited theoretical articles by journals of all time. Chou's dynamics equations and theory has been extended to illustrate the ancient Chinese philosophy and to advocate Econo-Green Bio-Research. He is Inventor/Co-inventor of 36 U.S. Patents, on Editorial Board of five international scientific journals, and is the founder of PD Science, LLC.

Research Interest

Biography

Dr. Olga S. Latinovic is an assistant professor working at the Institute of Human Virology (IHV) led by Robert C. Gallo, M.D. at the University of Maryland, School of Medicine in Baltimore, MD, USA. Her research focus is on developing novel antiviral therapy strategies using various HIV entry inhibitors, with a particular focus in understanding antiviral synergistic activity and its mechanism between CCR5 antagonists and CCR5 antibodies extensively collaborating with Dr. Robert R. Redfield, MD. Dr. Latinovic wrote the book Micromechanics and Structure of Soft and Biological Materials, and published by Verlag Dr. Muller in 2010, and co-authored the book Handbook of Photonics for Biomedical Engineering published by Springer-Verlag in 2016. Dr. Latinovic lectures Virus Entry course for the grad students at the Department of Microbiology and Immunology at the University of Maryland, School of Medicine.

Research Interest

Biography

Associate Professor Shubhada Bopegamage, MSc., PhD is a Virologist currently heading the Enterovirus Laboratory and the National Reference Center for Identification of Enteroviruses at the Medical Faculty of the Slovak Medical University in Bratislava, Slovakia. Her work is focussed on the pathogenesis and diagnosis of enteroviruses. She received her BSc. Microbiology degree from Pune, India and MSc. Microbiology degree from Mumbai, India. She got her PhD in Biological Sciences from the Academy of Medical Sciences, Moscow, Russia. She is known in the Enterovirus research since 2005 for her work on the in vivo experimental coxsackievirus oral infection of mice. She is involved in research and teaching and has guided several MSc. and PhD students. She has co-ordinated and has lead several national and international projects as a principal or co-investigator.

Research Interest

Biography

Dr. Nossik Nikolai N. Graduated from Moscow Medical University, physician. PhD (1960), Doctor of Science ( 1988), professor (1990). In 1968 - 1973 the WHO expert in SEARO (India) on national and international projects on virology and epidemiology. Main activity was connected with poliomyelitis in India and afterwords was conducted to enteroviruses in South-East Asia Region (India, Nepal, Burma, Thailand).In 1975 as a visiting scientist was doing the research study on oncornaviruses at the National Institute of oncology ( Fort Detrick). In 1976 and 1978 as visiting scientist was involved in the study on interferons (ISERM program) in Paris, France.Main scientific interests - antiviral and virucidal preparations, interferons , immunomodulators. He is the head of laboratory of virus ontogenesis in Ivanovsky Institute of virology, “N.F. Gamaleya FRCEM», Moscow, Russia. He has published 3 monographies, 6 books chapters and more than 200 papers in scientific journals.

Research Interest

Main scientific interests - antiviral and virucidal preparations, interferons , immunomodulators. He is the head of laboratory of virus ontogenesis in Ivanovsky Institute of virology, “N.F. Gamaleya FRCEM», Moscow, Russia. He has published 3 monographies, 6 books chapters and more than 200 papers in scientific journals

Biography

amal El Sawaf is a Professor of Microbiology and Immunology Medical Research Institute, Alexandria University, Egypt. He is a nationally recognized leader in infectious diseases. He was graduated from the Faculty of Medicine, Alexandria University in 1979. He has obtained his PhD in 1993 and his Post Doctor training course in the Laboratory of Infectious Diseases (Cattedra Di Clinica Delle Malattie Infettive) University of Rome, Tor Vergata. He was appointed as the Head of Microbiology Department in 2008 and the Director of the Medical Technology Center in 2010 and finally, the Dean of MRI. His main fields of research activities are in the clinical aspects pathogenesis and therapy of HCV, HIV and HHV-8 infection and epidemiology and molecular characterization of hepatitis viruses in Egypt. He has acted as a Referee for a variety of national and international scientific journals and as a Referee of research projects of the Alexandria University and of the STDF projects. He is a Member of the American Society of Microbiology, The Egyptian Society of Microbiology and Egyptian Society of Immunologists. He is a Project Leader of several research programs on HCV, HHV and TB

Research Interest

Biography

Dr.Zenab Torky is an Assistant Professor of Microbiology in the department of Microbiology, Faculty of Science, Ain Shams University, in Egypt. She also worked as a Visiting Scientist in the department of Biological Sciences, University of Louisville, USA. Dr.Zenab has also reviewed and edited many papers for the Food Safety Journal, and participated in two projects with members of the Remold laboratory in University of Louisville, to study the nature and conditions of adaptations of vesicular somatitis virus to a cancer cell line, using molecular biology techniques like genome sequencing and phenotypic characterization of recombinant viruses, to design oncolytic viruses that kill cancer cells, and sampling, genotypic and phenotypic characterization of Pseudomonas bacteria species isolated from human homes, and their pets.

Research Interest

Dr.Zenab’s main research interest is finding a way to protect living cells from viral infection, by studying ways to strengthen the immunity of the host by using natural compounds like antivirals, and studying their effect on viral replication

Biography

Dr. Hemida received his Ph.D from University of Guelph, 2009. He pursued his PDF training at the the University of British Columbia (James Hogg iCapture Centre). His research area of interest is “One Health Concept” with special emphasis on emerging viruses/host interaction. Currently, studying the molecular evolution and pathogenesis of MERSCoV in the Middle East. He published more than 40 original Research papers on high impacted journals. Meanwhile, he received several Research grants, prestigious honors and scholarship throughout his academic carrier. Currently, he is a reviewer of many granting agencies as well as editorial board member of many international journals

Research Interest

Study of the molecular evolution and pathogenesis of MERSCoV in the Middle East.

Organizing Committee - Euro Virology 2016

Biography

Dr. Farshad Guirakhoo, a virologist by training, was named one of the 50 Most Influential People in Vaccines in VaccineNation’s 2014 list. His most recent assignment was CTO at Vaxess Technologies. Prior to this, he served as CSO at Hookipa Biotech and Executive Director of External R&D at Sanofi Pasteur. Before joining Sanofi Pasteur in 2007, he was with Acambis for 15 years as Head of Research and co-invented the ChimeriVax-technology platform in association with St. Louis University. This platform has successfully been applied in the development of vaccines such as IMOJEV™, PreVenile™, Dengvaxia™, and WN human vaccine. Dr. Guirakhoo has broad experience in the application of gene expression technologies and molecular virology for the construction and production of recombinant proteins, human antibodies, and attenuated viral vectored vaccines for the prevention and treatment of infectious diseases. Dr. Guirakhoo is the author of over 80 peer-reviewed publications and holder of multiple patents.

Research Interest

Application of genetics, gene expression technologies and molecular virology for the constructions and productions of recombinant proteins, human antibodies and attenuated viral vectored vaccines for prevention and treatment of infectious diseases.

Biography

Dr Kedzierska trained as a viral immunologist and has over 14 years of experience in researching the immune responses to acute (influenza) and chronic (HIV) viral infections. Her expertise in both the murine system and human settings allows her to translate any of the key findings obtained from an easily manipulated mouse model into human viral immunology. Her PhD work undertaken at the Burnet Institute in Melbourne has provided an important contribution to our knowledge of AIDS pathogenesis by proposing the mechanisms of why HIV-infected patients develop specific opportunistic infections as their disease progresses, ultimately the cause of their death. Her PhD work was recognised by prestigious awards, including a 2001 Premier’s Commendation for Medical Research, 2002 Monash University Mollie Holman Doctoral Medal for the Best PhD Thesis and the NHMRC Peter Doherty Postdoctoral Fellowship to pursue her postdoctoral research with Nobel Laureate Professor Peter Doherty. She joined Professor Doherty’s laboratory upon his return to the Department of Microbiology and Immunology at the University of Melbourne in July 2002. During the four-year postdoctoral position she has further contributed to the field of viral immunology and developed her own research interests related to the cellular and molecular aspects of CD8+ T cell immunity to influenza virus infection. After being awarded the NHMRC RD Wright Fellowship and a NHMRC Project Grant, she established her independent research group in the Department of Microbiology and Immunology. She aims to understand how immunological T cell memory is generated, whether it is feasible to elicit immunity towards escape viral variants, and how T cell receptor repertoire relates to T cell phenotype, function and viral escape.

Research Interest

Biography

Dr. Barakat is an Assistant Professor at the school of Pharmacy at the University of Alberta, Canada. His research stands at the multidisciplinary interface of physics, biology and computer science. Dr. Barakat’s major focus is on developing and applying state-of-the-art computational drug discovery tools to discover new antiviral and immunotherapeutic drugs. Dr. Barakat has made great contributions in understanding the nature and biophysical processes underlying protein–drug, protein–protein and drug off-target interactions and predicting drug-mediated toxicity. He also received numerous awards including the CIHR and AIHS postdoctoral fellowships, the prestigious University of Alberta dissertation award and many distinction awards throughout his undergraduate and graduate studies. Dr. Barakat is also the editor of the Journal of Pharmaceutical Care & Health Systems and serves as a guest reviewer for several journals.

Research Interest

Biography

Hiroshi Ohrui was born in 1942. He received his B.S. (1965) and Ph.D. degrees (1971) from The University of Tokyo under the direction of Professor Masanao Matsui.
He joined RIKEN in 1966 as a researcher. In 1981, he moved to Tohoku University as Associate Professor in the Department of Food Chemistry, Faculty of Agriculture. In 1977, he was promoted to Full Professor, Graduate School of Life Science. In 2006, he moved to Yokohama University of Pharmacy as Professor.
He worked for Dr. J. J. Fox at Sloan Kettering Institute for Cancer Research (1972-1973) as a Research Associate, and for Dr. J. G. Moffatt at Syntex Research (1973-1974) as a postdoctoral fellow. He worked for The Technical University of Darmstadt as an invited professor by DAAD (1990). He has received several awards including The Agricultural Society of Japan Award for Young Scientists (1974), Inoue Prize for Science (2001), Japan Prize of Agricultural Sciences (2004), The Japan Society for Analytical Chemistry Award (2004), and The Japan Academy Prize (2010).

Biography

Research Interest

Biography

Dr. Keivan Zandi completed his Ph.D in Medical Virology from Tarbiat Modarres University, Iran. He is currently working as an associate professor in Department of Medical Microbiology, University Malaya. He has published more than 60 research papers in various Scientific Journals and has several patents on his name. He is actively severing as an Editorial Board Member for Scientific Reports with Nature publishing group as well as several other journals such as International Journal of Virology, SM tropical Medicine Journal, International Journal of Pharmacology, American journal of Drug Discovery and development, International Journal of Drug Discovery and Biotechnology journal.

Research Interest

Biography

Professor Ludmila Viksna is one of the most experienced experts in Infectology and Hepatology in Latvia. She is Chief Specialist of Infectology in Riga East Clinical University Hospital, Chief Infectologist of Ministry of Health of the Republic of Latvia, Head of the Department of Infectology and Dermatology in Riga Stradins University, Corresponding Member of Latvian Academy of Sciences and President of Association of Infectologists and Hepatologists of Latvia. Professor L.Viksna is the author of 5 books, more than 300 publications and she holds 15 patents.

Research Interest

Biography

Dr. Edmond Puca has received his PhD in University Hospital Center Mother Teresa during the period of 2010-2014. Currently, he is working as infectologue in University Hospital Center “Mother Teresa”.He is a member of Albanian Society of infectology.He is serving as an editorial member as well as reviewer for several reputed journals.

Research Interest

Biography

Associate Professor Angelika Krumina is PhD of Medical Sciences, Leading Researcher in Infectology field in Riga East Clinical University Hospital. A.Krumina is Scientific Expert of Latvian Academy of Sciences, Board Member of Latvian Medical Association and Member of European Society of Clinical Microbiology and Infectious Diseases.
During 2011-2012 she was Project Coordinator in State Programme of Latvian Academy of Sciences. Currently she is Work Package 6 leader in Latvia of Baltinfect project of the Seventh Framework Programme (FP7) of the European Commission.

Biography

Sunil Kumar Gupta has completed his PhD at the age of 32 years from King George\'s Medical University, Lucknow, INDIA. He is the Research Scientist of Bioinformatics, a premier Biotech Park, Lucknow India. He has published more than 12 papers in reputed journals and presented more than 15 research findings in National and International conferences.

Research Interest

His Research interest is in the area of infectious diseases specially on Genus Flavivirus.

Organizing Committee - Virology 2016

Biography

C. Yong Kang has completed his PhD from McMaster University in Canada and post-doctoral training at the University of Wisconsin-Madison. He served as a Professor of Virology at the University of Texas Southwestern Medical School, Professor and Chairman at the University of Ottawa Faculty of Medicine, and Dean of Science at the University of Western Ontario. He has published 137 peer reviewed research papers and 151 scientific proceedings and abstracts. He holds nine international biotechnology patents. He received numerous awards including the Ho-Am Prize in Medicine. He is a Life-time Fellow of the Royal Society of Canada Academy of Science. He serves as a reviewer for eight international journals.

Research Interest

His research in molecular virology includes the development of viral-specific antiviral therapeutic agents and efficacious vaccines against various human viral diseases including AIDS, hepatitis and hemorrhagic fever with renal syndrome.

Biography

DC Tang is the Founder of VaxDome LLC and Vaxin Inc. He was a pioneer during the development of DNA vaccines, noninvasive skin-patch vaccines, adenovirus-vectored vaccines, and the protective innate-adaptive immunity duo platform technology. He was selected as a Distinguished Overseas Scientist by the South Korea KOFST Brain Pool Program; subsequently joined Chung-Ang University and International Vaccine Institute in Seoul; and was appointed as a Scientist at IVI after the Brain Pool Program Award expired in 2013. He founded VaxDome LLC in Birmingham, Alabama, USA in 2014 and moved the company to Dallas, Texas, USA in 2015.

Biography

Professor Ting-Chao Chou received MS degree in Pharmacology from National Taiwan University College of Medicine; Ph.D. from Yale University, and Postdoctoral Fellowship at Johns Hopkins University School of Medicine. Joined Memorial Sloan-Kettering Cancer Center (MSKCC), became Member 1988-96, and a Professor of Pharmacology at Cornell University Graduate School of Medical Sciences, 1988-2000. He is Honorary Professor at Chinese Academy of Medical Sciences, Beijing and five other universities. He focused in the new drug discovery as the Director of Preclinical Pharmacology Core at MSKCC, where he retired on June1, 2013. His 273 scientific articles have been cited by 15,606 papers (as of 8.31.2014). (Thomson Reuters Web of Science: www.researcherid.com/rid/B-4111-2009). Prof. Chou introduced the “Unified Theory of the Median-Effect Equation of the Mass-Action Law”, and with Prof. Paul Talalay (JHU) in 1984, created the “Combination Index Theorem” for multiple entity dynamics. For one article alone (Chou TC and Talalay P., Adv Enz Regul 22:27-55, 1984), cited by 3,218 articles published in 599 biomedical journals and has become one of four the most broadly cited theoretical articles by journals of all time. Chou's dynamics equations and theory has been extended to illustrate the ancient Chinese philosophy and to advocate Econo-Green Bio-Research. He is Inventor/Co-inventor of 36 U.S. Patents, on Editorial Board of five international scientific journals, and is the founder of PD Science, LLC.

Research Interest

Biography

Ronald Moss, M.D. has served as the Chief Executive Officer of Ansun Biopharma, Inc. since October 2012, and before that, served as both interim CEO and Executive Vice President of Clinical Development and Medical Affairs at Ansun from 2008 to 2012. Dr. Moss has held various executive positions in the pharmaceutical industry for over 20 years and has played a pivotal role in successfully leading companies through the complexities of drug and vaccine development. Dr. Moss has been involved in drug and vaccine development of products in Infectious Disease, Allergy, Neurology, Dermatology, Oncology, Respiratory, Transplant, and Autoimmunity in both large pharmaceutical and biotechnology companies, including roles at Aventis, Immune Response, Merck, Telos and Vical. He has also authored over 70 scientific publications. Prior to joining industry, he received his M.D. degree from Chicago Medical School, completed a residency in pediatrics at SUNY Stony Brook and completed a fellowship at the National Institutes of Health. He is double boarded in Pediatrics and Allergy and Immunology. He is also a Fellow of the American Academy and American College of Allergy and Immunology

Research Interest

Biography

Sita Awasthi has received her Ph.D in Biochemistry from Devi Ahilya University at Indore, India and her postdoctoral training from University of Pennsylvania at Philadelphia. Currently she is a Research Assistant Professor at University of Pennsylvania, Pearlman School of Medicine, Infectious Disease Division. Her research interests are HSV-2 vaccine development against genital herpes disease and HSV-2 HIV-2 co-infections. She has published numerous research articles and serving as an editorial board member of Journals of antivirals and anti retrovirals, Journal of Immunoassay and Immunochemistry.

Research Interest

Biography

Walter Doerfler has completed Munich Medical School (LMU), Doctor of Medicine thesis in Anatomy and Internships in Munich and Trenton, NJ, USA. He did his Postdoctoral studies in Molecular Genetics at the Max-Planck-Institute for Biochemistry in Munich and in the Department of Biochemistry, Stanford University Medical School.

Research Interest

Biography

Zhanglei has completed her PhD at the age of 30 years from Heping Campus Jilin University. Now she is a associate professor and postgraduate tutor of institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences. Mainly engaged in fur animal disease including molecular epidemiological investigation and diagnosis products research work

Research Interest

Mainly engaged in fur animal disease including molecular epidemiological investigation and diagnosis products research work

Biography

Marcin Sieńczyk graduated from the Molecular Biotechnology and Biocatalysis program in 2002 at Wroclaw University of Technology, four years later he obtained his PhD in Medicinal Chemistry. In 2015 he was awarded habilitation (DSc) in Biotechnology. He currently holds the position of assistant professor at Wroclaw University of Technology, Division of Medicinal Chemistry and Microbiology. His research is focused on the development of low molecular weight compounds designed to target proteases involved in the pathogenesis of various diseases including cancer, bacterial and viral infections. Work in his laboratory also generates antibodies to be used in the development of new diagnostic assays for human diseases. He is a co-author of more than 40 papers, 14 patents and more than 25 pending patent applications.

Research Interest

Biography

Dr.Zenab Torky is an Assistant Professor of Microbiology in the department of Microbiology, Faculty of Science, Ain Shams University, in Egypt. She also worked as a Visiting Scientist in the department of Biological Sciences, University of Louisville, USA. Dr.Zenab has also reviewed and edited many papers for the Food Safety Journal, and participated in two projects with members of the Remold laboratory in University of Louisville, to study the nature and conditions of adaptations of vesicular somatitis virus to a cancer cell line, using molecular biology techniques like genome sequencing and phenotypic characterization of recombinant viruses, to design oncolytic viruses that kill cancer cells, and sampling, genotypic and phenotypic characterization of Pseudomonas bacteria species isolated from human homes, and their pets.

Research Interest

Dr.Zenab’s main research interest is finding a way to protect living cells from viral infection, by studying ways to strengthen the immunity of the host by using natural compounds like antivirals, and studying their effect on viral replication.

Biography

Girish J. Kotwal, received his Ph.D. from the Biochemistry department, McMaster University, Canada in 1985. He did his post doctoral work at the National Institutes of Health (NIH) in Bethesda, MD, USA in the Laboratory of Viral Diseases from 1984-1990 and co-discovered the vaccinia virus complement control protein (VCP) along with Dr. Bernard Moss, member of the US National Academy of Science (NAS). During the 90s he established a structural biology program which included overexpression of VCP, a heavily disulphide bonded protein and directed the preclinical program to evaluate the therapeutic potential of VCP. In 2002 he founded Kotwal Bioconsulting, LLC, in 2004 he founded kbiotech pvt. ltd., in South Africa, in 2005 he co-founded InFlaMed Inc. in USA. In 2010 he assisted in founding Icelandic Cardio Pharma (IceCP) in Iceland. He is currently Professor of Biochemistry and Microbiology at UMHS, WI, Adjunct Professor of Medicine, UMass medical school, Worcester, MA and Adjunct Professor of Traditional Chinese Medicine at Henan University, China. He has authored over 100 publications, 97 of which are found on pubmed.

Biography

Dominic Targema Abaver has completed his Ph.D.at the age of 40 years from University of Abuja in parasitology; He is chief superintendent of Immigration Nigerian Immigration service, a paramilitary organization in the ministry of interior. He has published number of papers on HIV/AIDS, Immunology and parasitology in reputed journals, such as African Health Science, Pakistani Journal of Medical sciences, African Journal for Physical, Health Education, Recreation and Dance (AJPHERD). He is a member of Nigerian society of parasitology and a fellow, Institute of Cooperate Administration. Currently, D.T. Abaver is a Contract Researcher at Walter Sisulu University, Eastern Cape, South Africa. His research interest include Epidemiology of HIV/AIDS and other Opportunistic Infections; Preventive measures/techniques of HIV/AIDS; gender, age and sexual orientation as determinants for the impact of HIV/AIDS

Research Interest

Biography

Dr Benani is a responsible of Molecular Biology Laboratory at Pasteur Institute of Morocco this laboratory is a national reference laboratory for Hepatitis C Program (Moroccan ministry of health). He is also the elect-president of Arab Society for Virology and Active member on the Advisory Board, Consultative Meeting on Regional Strategy for Prevention and Control of Viral Hepatitis and Other Epidemics-Prone Blood-Borne Diseases, in 2008 (WHO/EMRO, Cairo, Egypt). He got his master of molecular biology and biotechnology at Université Libre of Bruxelles (ULB, Belgium) and his PhD in molecular microbiology in Fes University (Morocco). He participates in several international and national workshops and congresses. He is also implicated in student’s research for their training, master, and PhD. He published in several journals including journal of medical virology, BMC public health, Virology Journal, He is an active researcher in molecular epidemiology of HBV and HCV in general population and high Risk groups in Morocco. He organized the 1st International Symposium for Virology in Morocco in 2003 (Marrakech, Morocco) and the First PCR Forum and Molecular Typing at Pasteur Institute of Morocco

Research Interest

Molecular epidemiology of HBV and HCV

Organizing Committee - Virology-2015

Biography

Ronald Moss, M.D. has served as the Chief Executive Officer of Ansun Biopharma, Inc. since October 2012, and before that, served as both interim CEO and Executive Vice President of Clinical Development and Medical Affairs at Ansun from 2008 to 2012. Dr. Moss has held various executive positions in the pharmaceutical industry for over 20 years and has played a pivotal role in successfully leading companies through the complexities of drug and vaccine development. Dr. Moss has been involved in drug and vaccine development of products in Infectious Disease, Allergy, Neurology, Dermatology, Oncology, Respiratory, Transplant, and Autoimmunity in both large pharmaceutical and biotechnology companies, including roles at Aventis, Immune Response, Merck, Telos and Vical. He has also authored over 70 scientific publications. Prior to joining industry, he received his M.D. degree from Chicago Medical School, completed a residency in pediatrics at SUNY Stony Brook and completed a fellowship at the National Institutes of Health. He is double boarded in Pediatrics and Allergy and Immunology. He is also a Fellow of the American Academy and American College of Allergy and Immunology

Research Interest

Biography

Dr. Chen currently is the Deputy Director of Alaska State Public Health Virology Laboratory and an Associate Professor in the Department of Biology and Wildlife and Institute of Arctic Biology at the University of Alaska Fairbanks. Dr. Chen's research activity focuses on the diagnosis and research of public health related viral infection in Alaska. His Virology Laboratory is a joint effort between State of Alaska Public Health Division and University of Alaska Fairbanks. Current research projects involve both clinical and basic virology research. Dr.Chen obtained his Ph.D. Degree in Virology at Osaka University Medical School in Japan and his post doctorate training at University of British Columbia at Vancouver, Canada.

Research Interest

The clinical research focuses on molecular diagnosis of viral infections, as well as technology development for the diagnosis of emerging human pathogens. The basic research in this lab involves in the virus-human cell interaction and the role of tumor virus in human tumorigenesis.

Biography

Girish J. Kotwal, received his Ph.D. from the Biochemistry department, McMaster University, Canada in 1985. He did his post doctoral work at the National Institutes of Health (NIH) in Bethesda, MD, USA in the Laboratory of Viral Diseases from 1984-1990 and co-discovered the vaccinia virus complement control protein (VCP) along with Dr. Bernard Moss, member of the US National Academy of Science (NAS). During the 90s he established a structural biology program which included overexpression of VCP, a heavily disulphide bonded protein and directed the preclinical program to evaluate the therapeutic potential of VCP. In 2002 he founded Kotwal Bioconsulting, LLC, in 2004 he founded kbiotech pvt. ltd., in South Africa, in 2005 he co-founded InFlaMed Inc. in USA. In 2010 he assisted in founding Icelandic Cardio Pharma (IceCP) in Iceland. He is currently Professor of Biochemistry and Microbiology at UMHS, WI, Adjunct Professor of Medicine, UMass medical school, Worcester, MA and Adjunct Professor of Traditional Chinese Medicine at Henan University, China. He has authored over 100 publications, 97 of which are found on pubmed.

Biography

C. Yong Kang has completed his PhD from McMaster University in Canada and post-doctoral training at the University of Wisconsin-Madison. He served as a Professor of Virology at the University of Texas Southwestern Medical School, Professor and Chairman at the University of Ottawa Faculty of Medicine, and Dean of Science at the University of Western Ontario. He has published 137 peer reviewed research papers and 151 scientific proceedings and abstracts. He holds nine international biotechnology patents. He received numerous awards including the Ho-Am Prize in Medicine. He is a Life-time Fellow of the Royal Society of Canada Academy of Science. He serves as a reviewer for eight international journals.

Research Interest

Biography

Professor Jun-Wen Li, doctoral supervisor at institute of Health and Environmental Medicine, is the academic leader of environmental hygiene. He was appointed as a visiting scholar to the Water Research Centre, University of New South Wales in the Australia (2006.9-2007.9) because of his outstanding work. His research has been supported by more than 20 foundation-programs. He has published more than 20 papers in reputed journals and has been serving as an editorial board member of many journals.

Research Interest

His major interests are microorganisms detection technology in water and food, disinfection of drinking water and safety evaluation for recycle water.

Biography

Dr. Yefei Zhu, is the Deputy Chief and Team Leader for the outbreak response team in the
Department of Acute Infectious Diseases Outbreak Response and Prevention, Jiangsu Provincial
Center for Disease Control and Prevention in China. During his 8 years with the Jiangsu CDC, He received his M.D.
degree from Nanjing Medical University, Nanjing, China in 2006. He was certified as professor
Jiangsu Province Science and Technology Department, Nanjing, China in 2014. His research
interests draw on the interplay between epidemiology and public health. His research has
focused on the epidemiology of infectious diseases, with recent emphasis on molecular and
geographic applications in Jiangsu, China. His research involves extensive collaboration with
colleagues from other disciplines, including microbiology, geography, public health, climate
change, et al.

Biography

Dr. Narasaiah Kolliputi is an Associate Professor and Division Director of Research Education for Division of Allergy and Immunology at the Morsani College of Medicine. Kolliputi is working on translational strategies to attenuate oxidative stress mediated acute lung injury (ALI) and pulmonary fibrosis. He received his postdoctoral training in the Massachusetts General Hospital, Harvard Medical School. Kolliputi is currently serving as a grant reviewer for the National Institute of Health, Department of Defense and American Heart Association Grants. He is an Associate Editor for Frontiers in Pharmacology, Frontiers in Physiology, Frontiers in Genetics and Guest Associate Editor for Frontiers in Mitochondrial Physiology, Editorial Board Member for Translational Medicine, Virology & Mycology and Journal of Biocatalysis & Biotransformation. Dr. Kolliputi’s research is funded by NIH RO1 and American Heart Association Scientist Developmental grants.

Biography

Dr. Barakat is an Assistant Professor at the school of Pharmacy at the University of Alberta, Canada. His research stands at the multidisciplinary interface of physics, biology and computer science. Dr. Barakat has made great contributions in understanding the nature and biophysical processes underlying protein–drug, protein–protein and drug off-target interactions and predicting drug-mediated toxicity. He also received numerous awards including the CIHR and AIHS postdoctoral fellowships, the prestigious University of Alberta dissertation award and many distinction awards throughout his undergraduate and graduate studies. Dr. Barakat is also the editor of the Journal of Pharmaceutical Care & Health Systems and serves as a guest reviewer for several journals.

Research Interest

Dr. Barakat’s major focus is on developing and applying state-of-the-art computational drug discovery tools to discover new antiviral and immunotherapeutic drugs.

Biography

Dr Nguyen Van Bang finished his PhD in Amiens University, France in 2005 and has awarded Associate Professor in 2009 and becomes Executive Member of Vietnam Pediatric Association and Vice-President of Vietnam Pediatric Digestive Association since 2010. He is director of an international scientific project (origin of the proposed communication), of 2 national and 3 ministerial ones and numerous hospital and community based studies. He has published more than 100 scientific papers in reputed international and national journals in medicine and healthcare (5 in French, 7 in English and more than 90 in Vietnam). He has presented more than 20 communications in world and international congresses.

Research Interest

Biography

Dr. Patricia Araujo received her Ph.D. from the University of Cambridge (UK) and was a post-doctoral fellow in the Molecular Virology Department at the Federal São Paulo University (Brasil).

Research Interest

She is now an Chief of Virology and Serologic screen laboratories at the Blood Bank- Colsan of Federal São Paulo University.She has a long standing interest in the molecular biololgy of hepatitis B virus, mechanisms of virus replication and virus host cells interactions that result in innate immune responses to infection.

Biography

Dr Massimo Cecaro after completing the high school in humanistic studies, he moved to the University of Camerino, where he got a Master Degree in Veterinary Medicine and in University of Teramo he successfully got the Specialization. Since the age of 14, he has worked as radio speaker, tv presenter and reporter for a wide range of artistic and scientific events. At the age of 24 he obtained a qualification to practice as a Journalist and in 2007 he was admitted to the National Association of Medical Press (ASMI), where he currently hold the position of National Councilor. He is Resident Member of MJA Medical Journalists’ Association (London). He is Member of EFSA's Expert Database. He has been an invited speaker,mentor and chairman at International events in the field of Public Health and Safety in Canada, US, Europe and Asia. He has been author of several scientific works in public health. He is also director in Italy of a prestigious Educational Centre for work safety and public health. He is actively involved in international projects to improve the role of mass-media in medical sciences, and awarded in Philadelphia, Valencia and Las Vegas with International special recognition. He is serving as an editorial member of several reputed journals like: “Journal Food Processing Technology”, “Journal of Veterinary Science & Technology”, and Editor in Chief in the “Occupational Medicine & Health Affairs” and in “Journal of Mass Communication”. He is Reviewer for "Journal od Cancer Science & Therapy”. He is Organizing Commette Member of several International Conferences in US and in Europe

Biography

Paul B.Fisher is Professor & Chairman, Department of Human and Molecular Genetics and Director, VCU Institute of molecular Medicine, Virginia Commonwealth University School Of medicine ,Richmond , Virginia, Research focuses on three broad areas; cancer, neurodegeneration & infectious diseases. A primary aim is to move discoveries made in the laboratory into the clinic, the concept of “bench-to-bedside”. He is among the top 5% of NIH funded investigators over the past 25 years, published over 400 primary papers and review articles, serves on many US government and private review panels and has over 55 issued US and numerous international patents.

Research Interest

Innovative approaches to discovery and molecular characterization of genes involved in susceptibility to cancer, neurodegeneration and infectious diseases.

Biography

Dr. Babita Agrawal is a professor in the Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. She completed M.Sc. (1987) in biochemistry and PhD (1993) in Immunology. After completing post-doctoral work, she joined a major Canadian biotech company in 1996 where she received outstanding R & D achievement awards for consecutive years and rose to the position of Manager and Head of Immunology Research. She headed a large group of scientists, focusing on basic to translational research on novel immunotherapy and vaccine technologies, leading to clinical trials. In 2001, she joined the University of Alberta as an assistant professor and received a Medical Scholar Award in 2002 from the Alberta Heritage Foundation for Medical Research (AHFMR). In 2007, she was promoted to the rank of associate professor with tenure. In the same year she obtained a Senior Scholar Award from the Alberta Innovates Health Solutions (AIHS). In 2011, she was honored by Dean’s Award in the Faculty of Medicine and Dentistry, U of Alberta. In 2013, she was promoted to full professor. She is an established investigator with proven leadership in immunotherapy and vaccine research. In addition to a number of provincial and national grant committees, she has served as an external scientific expert in cellular immunology and vaccine research on NIH and NCI, U.S.A., grant panels and site visits.

Research Interest

Her research focuses on studying immune regulation and innate and adaptive immune responses, and novel small molecule inhibitors against viral infections and cancer, in order to design and study novel vaccine, immuno- and chemo-therapeutic strategies. She has published several pioneering papers in the field and has a number of issued patents. Recently, she has co-founded a small biotech based on her research in the areas of vaccine and therapeutics.

Biography

Dr.A.K.Prasad is the currently working as President of Indian Virological Society.He is also the chairman of Influenza Foundation of India.He was elected Fellow of the Geriatric Society of India (FGSI) 2014 at their Nagpur Convention (8-9 November, 2014).He has also Published over 60 Research Papers in national & International Journals & 3 Books (Chapter on Influenza).He has also received Life Time Achievement Award conferred by the Geriatric Society of India on 06th November, 2014 at the Vaccine Advocacy for the S E Asian Countries held at Delhi.

Research Interest

Biography

Dr Atmaram Bandivdekar completed his Ph D Degree at the age of 31 years from Mumbai University. Bandivdekar was the Post-Doctoral and Carrier fellow at Population Council, New York. He was also the visiting scientist at UC Davis Primate Center. He is the Deputy Director of National Institute for Research in Reproductive Health which is the premier Institute in India in the field of Reproductive Health Research. He has published more than 70 papers in peer reviewed journals and also the book and two conference proceedings. He also has six National and International awards for his scientific contributions. Bandivdekar is actively involved research on understanding sexual transmission of HIV and development of preventive and therapeutic vaccine and formulation for prevention of HIV transmission.

Research Interest

Biography

Dr. Hemida received his Ph.D from University of Guelph, 2009. He pursued his PDF training at the the University of British Columbia (James Hogg iCapture Centre). His research area of interest is “One Health Concept” with special emphasis on emerging viruses/host interaction. Currently, studying the molecular evolution and pathogenesis of MERSCoV in the Middle East. He published more than 40 original Research papers on high impacted journals. Meanwhile, he received several Research grants, prestigious honors and scholarship throughout his academic carrier. Currently, he is a reviewer of many granting agencies as well as editorial board member of many international journals.

Research Interest

Biography

Dr Benani is a responsible of Molecular Biology Laboratory at Pasteur Institute of Morocco this laboratory is a national reference laboratory for Hepatitis C Program (Moroccan ministry of health). He is also the elect-president of Arab Society for Virology and Active member on the Advisory Board, Consultative Meeting on Regional Strategy for Prevention and Control of Viral Hepatitis and Other Epidemics-Prone Blood-Borne Diseases, in 2008 (WHO/EMRO, Cairo, Egypt). He got his master of molecular biology and biotechnology at Université Libre of Bruxelles (ULB, Belgium) and his PhD in molecular microbiology in Fes University (Morocco). He participates in several international and national workshops and congresses. He is also implicated in student’s research for their training, master, and PhD. He published in several journals including journal of medical virology, BMC public health, Virology Journal, He is an active researcher in molecular epidemiology of HBV and HCV in general population and high Risk groups in Morocco. He organized the 1st International Symposium for Virology in Morocco in 2003 (Marrakech, Morocco) and the First PCR Forum and Molecular Typing at Pasteur Institute of Morocco

Research Interest

Biography

Professor Ting-Chao Chou received MS degree in Pharmacology from National Taiwan University College of Medicine; Ph.D. from Yale University, and Postdoctoral Fellowship at Johns Hopkins University School of Medicine. Joined Memorial Sloan-Kettering Cancer Center (MSKCC), became Member 1988-96, and a Professor of Pharmacology at Cornell University Graduate School of Medical Sciences, 1988-2000. He is Honorary Professor at Chinese Academy of Medical Sciences, Beijing and five other universities. He focused in the new drug discovery as the Director of Preclinical Pharmacology Core at MSKCC, where he retired on June1, 2013. His 273 scientific articles have been cited by 15,606 papers (as of 8.31.2014). (Thomson Reuters Web of Science: www.researcherid.com/rid/B-4111-2009). Prof. Chou introduced the “Unified Theory of the Median-Effect Equation of the Mass-Action Law”, and with Prof. Paul Talalay (JHU) in 1984, created the “Combination Index Theorem” for multiple entity dynamics. For one article alone (Chou TC and Talalay P., Adv Enz Regul 22:27-55, 1984), cited by 3,218 articles published in 599 biomedical journals and has become one of four the most broadly cited theoretical articles by journals of all time. Chou's dynamics equations and theory has been extended to illustrate the ancient Chinese philosophy and to advocate Econo-Green Bio-Research. He is Inventor/Co-inventor of 36 U.S. Patents, on Editorial Board of five international scientific journals, and is the founder of PD Science, LLC.

Research Interest

Biography

Sevgi Ciftci is the Associate Professor at the the Department of Microbiology, Faculty of Dentistry, Istanbul University, Turkey. Dr. Sevgi Ciftci obtained her BA in department of the medical biological sciences in Faculty of Medicine from the Dokuz Eylül University at Izmir- Turkey, and her PhD in Microbiology from the Medical Faculty of Istanbul University at Istanbul, in 2003.

Research Interest

Biography

Robin J Green is Director of Paediatric Services and Paediatric Pulmonology, Paediatric Intensive Care and Allergy Services at the Steve Biko Academic Hospital, Pretoria. He is a Full Professor in the Department of Paediatrics and Child Health within the School of Medicine at the University of Pretoria. He holds a PhD and DSc, and is a fellow of the Royal College of Physicians and Past President of the College of Paediatricians of South Africa. He is also Immediate Past Chairman of the Allergy Society of South Africa. The National Research Foundation rates him as an established researcher, in paediatric pulmonology.

Research Interest

Paediatrics and Child Health

Organizing Committee - Virology-2013

Biography

Marc H V Van Regenmortel is currently an Emeritus Research Director at the CNRS (French National Research Center) in the School of Biotechnology of the University of Strasbourg, France. He was for 22 years Director of the Immunochemistry Laboratory at the CNRS Molecular Biology Institute in Strasbourg and previously was a professor at several universities in South Africa and France. He served (1984-1990) as Vice Chairman and Chairman of the Virology Division of the International Union of Microbiological Societies (IUMS) and was Secretary General of IUMS from 1990 to 1999. He was also for six years (1996-2002) President of the International Committee on Taxonomy of Viruses. He supervised the research work of 30 PhD students and has published 395 research and review papers as well as 17 books in the fields of Virology and Immunochemistry. In 2009 he co-edited with Brian Mahy of the CDC in Atlanta, the third edition of the Encyclopedia of Virology in 5 volumes published by Elsevier.
He is currently Editor-in-Chief of ARCHIVES OF VIROLOGY and JOURNAL OF MOLECULAR RECOGNITION, an Executive Editor of ANALYTICAL BIOCHEMISTRY, an Associate Editor of ADVANCES IN VIRUS RESEARCH, FRONTIERS IN IMMUNOTHERAPIES AND VACCINES, JOURNAL OF IMMUNOLOGICAL METHODS, ISRN IMMUNOLOGY, BIONOMINA and EXPERT REVIEWS OF PROTEOMICS

Research Interest

Biography

After graduating at the Faculty of Veterinary Medicine, University of Helsinki, Finland in 1986 I worked for 16 years as a private veterinary surgeon in southern Finland mainly in small animal and mixed practice. Between 2002 and 2004 I completed research-based Master’s degree studies on virology at the Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, South Africa on the detection of lumpy skin disease virus (LSDV) in samples of experimentally infected cattle using different diagnostic techniques. In 2004 I was employed by The Pirbright Institute as a research scientist to set up the full diagnostic capacity for capripoxviruses. Since 2006 I have been heading the World Organization for Animal Health (OIE) reference laboratory for lumpy skin disease (LSD), sheep pox (SPP) and goat pox (GTP) in Pirbright, UK. In 2007 I was appointed as OIE’s international expert for LSD, SPP and GTP. Since 2006 I have also been responsible of the veterinary care of experimental animals at Pirbright as a Named Veterinary Surgeon. My special interest in the research field for capripoxviruses is the epidemiology, control and eradication of the diseases as well as training and enhancement of diagnostic capacity for capripoxviruses in local and national reference laboratories in developing countries. Since late 2006 I have been investigating the role of hard tick vectors in the transmission of LSDV.

Biography

Research Interest

Biography

Sharof Tugizov is an Associate Professor in the Department of Medicine, University of California San Francisco. He earned his PhD and BSc degrees from the Institute of Virology, Russian Academy of Medical Science.

Research Interest

Biography

Teaching within the Faculty of Health Sciences includes the following: Residents in the Medical Microbiology/ Infectious Diseases and Pathology Residency Training Programs, Graduate Course in Clinical Virology (MS763), Graduate students thesis supervision in my laboratory, and Supervisory Committee member for six graduate students in medical Sciences.

Research Interest

The major focus of our research is the pathophysiology of acute respiratory infections caused by specific viruses (influenza, RSV) and bacteria (Chlamydia pneumoniae, P. aeruginosa and C. difficile).

Biography

Dr Aboul-Ata Elnady ABOUL-ATA, Professor Dr. of Plantvirology, who was born on Mar.22nd 1948 in Sharkia, Egypt, is the president of ArSV (Arab Society for Virology) in 2013 for 3 years. He was formerly Department Head of Plant Virus and Phytoplasma Research, Plant Pathology Research Institute at Agricultural Research Center, Giza, Egypt for 3 years (2003-2006), and Head of Molecular laboratory at Plant Virus and Phytoplasma Res. from Sep. 2005 up to now.
In 2007 he has been awarded committee membership of Egyptian Society of Advanced Material and Nano Technology. He is being a committee-member of Egyptian Society of Virology since initiation in 2001. He is being member of the Molecular Virology Group at the University of Kentucky, USA, American Phytopathological Society, The New York Academy of Sciences, American Society for Microbiology, Federation of British Plant Pathologists (FBPP) UK, Egyptian Society of Entomology, Egyptian Society of Plant Pathology, Egyptian Society of Applied Microbiology, African Virology Associan (AVA), South Africa, Who\'sWho in the World, Record # World-18, 2001 GNNF 2852757104, USA.
Dr. Aboul-Ata is the author of more than 40 scientific papers in different approaches i.e. gene silencing, sequencing of viral genes. He is being the author of Chapters in different books i.e. Mediterranean Link Committee for Processing Tomato Research (MELCOPTOR) Book and Virus Diseases and Control in Arab World. As new era of research, he is leading an Egyptian research group (human virologists and molecular biologists) for a Swedish-funded project on Plant-based vaccine against HSV-2 in collaboration with Gothenburg University, Sweden throughout 2007-2010. He also leading a MERC project on detection of cereal viruses for prevention through quarantine system in Middle East countries (Egypt, Jordan, Israel and Palestine) throughout 2008-2011, appointed for funding. He is being in charge of nanoscience introduction to the domain of plant virology at Plant Pathology Research Institute. He brings his research a unique relationship study between viruses and insect vectors. He has introduced advanced thinking in virus epidemiology and molecular epidemiology, virus and Antiserum Bank, at the Dept. of Plant Virus and Phytoplasma Res. He is being chosen for general-, scientific- and organizing-committee member for the First and 2nd Conference of Virology, which was organized by ESV at 2004 and 2008, Cairo, Egypt. He has also been chosen to be International Advisory-committee member for the 2nd Green revolution in India that is organized 2-5 July, 2009. He is an evaluation-committee member for promotion to higher scientific position i.e. Assoc. Professorship and Professorship at Institute of Plant Pathology, ARC, Egypt 2008 up to now.
Dr. Aboul-Ata has been chosen for reviewing at International Journal of Virology (IJV), ANSInet, and has been invited for reviewing at Biotechnology and Molecular Biology Reviews (BMBR), Academic Journals. Reviewing starts 2006-2009. He has reviewed more than 35 articles for both journals. He is also editorial board member of Egyptian Journal of Virology (Egyptian J. Virol.) as well as Indian Scientific Journals. He has been reviewing for Journal of Virological Methods. He also has been invited to be an editor for Briefings in functional Genomics and Proteomics, one of Oxford Journals.

Research Interest

Biography

Hye Kyung Chung received her Ph.D from Kun-kuk University and she studied the pathogenesis and molecular mechanism of retroviruses as a postdoctoral fellow at the National Institutes of Health. She has spent the majority of her research career studying molecular virology, recently pathogenesis of human and animal lentiviruses. She studies NHP models of retroviral latency and reactivation collaborating with Dr. Pincus. Dr. Chung continues to develop cutting-edge new assays to study viral reservoirs.

Biography

Dr. Deepak Shukla has received his PhD in Microbiology and Immunology from the University of Illinois at Chicago (UIC) during the period of 1990-1996. Currently, he is working as the Marion Schenk Esq. Professor of Ocular Virology in the Departments of Ophthalmology &Visual Sciences and Microbiology & Immunology at UIC College of Medicine in Chicago, IL. He is also the Director of Ocular Virology Laboratory at UIC. He serves on the editorial boards of prestigious journals, has been a regular reviewer for over a dozen reputed scientific journals, and has authored over 50 peer-reviewed papers including publications in top rated journals such as Cell, Journal of Clinical Investigation, Journal of Cell Biology, Journal of Biological Chemistry etc. He has also written two book chapters and holds two international patents for his discoveries. He was the lead discoverer of 3-O sulfated heparan sulfate as the host cell membrane receptor for herpes simplex virus. He has received outstanding research awards from many
organizations including American Herpes Foundation, Research to Prevent Blindness Inc. an

Research Interest

Dr. Shukla’s main research interest focuses on cell biology of virus entry into human cells. He has identified host cell membrane receptors for viruses such as herpes viruses. He is currently studying how membrane receptors and membrane morphology facilitate viral infections. Apart from heparan sulfate
proteoglycans, he also studies HVEM, a member of tumor necrosis factor receptor family and nectin-1, a member of immunoglobulin superfamily.

Biography

David Andrew Jans is a leading cell biologist who is widely recognized internationally for his seminal accomplishment in elucidating the process of nucleocytoplasmic transport and signal transduction in health and disease. His research career includes more than 250 refereed scientific papers (16 with over 100 citations, and 3 with over 300; over 9000 citations in all), multiple invitations to present at international conferences (7 plenaries, 2 keynote addresses, and 2 closing remarks speeches in the last 12 years), editorial board memberships of several eminent journals, and a H-index of 54. His meritorious awards include: IRPC (International Research Progress Council) Eminent Scientist of the Year (1999), the Danny Thomas Lecture Series Visiting Professor (St. Jude Childrens Research Hospital, Memphis, 2005), Japan Society for the Promotion of Science Senior Short-term Fellowship (2008), the GE

Biography

Research Interest

The core research activities in my laboratory are in-depth investigations of viral diseases, their pathogenesis, treatment and prevention and virus-host interactions, including the role of soluble mediators and cell subsets in virus-induced disease.

Biography

Shahzad, currently based in Vienna, Austria, is one of the pioneers, working for the progress of Translational Medicine (TM) field. Prof. Shahzad is currently serving as Director of Administration and Secretary General for “International Society for Translational Medicine (ISTM)”. He is also acting as a chair for Translational Medicine SIAC group at ‘Dug Information Association’ (DIA). Prof. Shahzad is serving as editor-in-chief for ‘Molecular Medicine & Therapeutics (MMT) Journal and for ‘Translational Biomedicine’ Journal. Prof. Shahzad has advised and participated in establishing Translational Medicine infrastructure for several organizations. Dr. Shahzad is invited speaker for many international life sciences conferences. He is professor of Microbiology and Professor of Medicine, at Harbin Medical University. In addition, various organizations are getting benefited from wide expertise of Prof. Shahzad in his capacity as a medical advisor and medical scientific expert.BIOGRAPHY

Research Interest

Biography

Shih-Shun Lin has completed his Ph.D at 2001 from National Chung-Hsing University and postdoctoral studies from The Rockefeller University. Currently, he is the assistant professor of Institute of Biotechnology, National Taiwan University. He has published more than 21 papers in reputed journals in plant virology and plant molecular biology fields. He also is a adjunct research fellow in Genome Biology and Systems Biology Degree Program, NTU, and Agricultural Biotechnology Research Center, Academia Sinica (Taiwan).

Research Interest

The expertises of Dr. Lin are plant molecular biology and virology, biotechnology, and high-throughput next generation sequence technology.

Organizing Committee - Clinical Virology 2017

Biography

Professor Huseyin Yilmaz was graduated from the Veterinary Faculty of Istanbul in 1984, and PhD in immunology from the Veterinary School at University of Bristol in 1993. Professor Huseyin joined Department of Microbiology of Istanbul Veterinary Faculty in 2001 and established the Department of Virology in the Veterinary Faculty of Istanbul in 2006. As a principal investigator, Professor Huseyin led a number of research projects and established research infrastructure to improve detection, epidemiology and prevention of major viral diseases and emerging viral infections affecting animals and public health. These projects were funded by TUBITAK and the University of Istanbul. He also established national and international collaboration with Turkish and European Union institutions through COST actions. Recently, we also established a bilateral research link between The Pirbright Institute and Department of Virology has been funded by the British Council concerning the viral livestock diseases related to food security. After recent outbreaks of lumpy skin disease in Turkey, he is also working on detection and prevention of transboundary emerging infections like LSD and is collaborating with the researchers in the Pirbright Institute, UK to apply a project to Horizon 2020 on LSD.

Research Interest

Detection and prevention of Trans boundary Emerging Infections like LSD

Biography

Professor Nuri Turan is currently working at the Department of Virology, Faculty of Veterinary Medicine, Istanbul University, Istanbul, Turkey. Nuri obtained Veterinary Medicine and MSc degrees in 1987 and, a PhD in Veterinary Microbiology in 1995 in Turkey. He has been for 3 months to study some immunological techniques at University of Bristol, Veterinary Medicine in 1990. He has been working as research scientist and senior lecturer -teaching viral diseases - at Istanbul University since 1998. He has taken part in a number of research projects and has had about 40 publications in peer reviewed international journals on bacterial and viral infectious diseases with particular interest in Zoonotic and vector-borne diseases. He has been at K-State University, USA for one year (2011-12) to conduct a project about avian influenza.

Research Interest

Biography

I was graduated from the Veterinary Faculty of Istanbul in 1995. After graduation, I have finished PhD at the Veterinary Faculty of Istanbul. I have joined to TUBITAK – MAM food science and technology and worked there 7 years. I have been an audit for Turkish accreditation for more than 7 years. I worked in Cevre Analyses Laboratory for 10 years as a technical manager. I have recently joined to Department of Virology in the Veterinary Faculty of Istanbul and currently working on veterinary and zoonotic viruses.

Research Interest

Biography

Dr. Sabiha Imran is a Medical Microbiologist and Associate Professor in the Department of Biotechnology, Faculty of Engineering and Science, Manav Rachna University, Faridabad, INDIA. She has more than 20 years research and teaching experience She earned her PhD in Medical Microbiology from JN Medical College, Aligarh Muslim University .She published research papers in reputed journals and presented papers in many national and International journals .She received best paper presentation award from All India Medical Sciences .She is a gold medalist and a qualified Registered microbiologist of Canadian College of Microbiology(RMCCM).Her area of research interest is the study on Bacteriocin as an anticancer, antiviral agent and an alternative to antibiotics and immunochemotherpeutic approach for the treatment of visceral leishmaniasis

Research Interest

Study on Bacteriocin as an anticancer, antiviral agent and an alternative to antibiotics and immunochemotherpeutic approach for the treatment of visceral leishmaniasis

Biography

Nahla is a very interested and positive person who did her best to fulfill the project goals, and succeeded in doing so. Nahla was also a positive factor in my group, and was liked by all of us. I am a very enthusiastic, active, and eager to learn. As well I have a broad experienced in the development and performance of clinically useful real-time PCRs and molecular tools in clinical virology aspects.

Research Interest

Molecular tools in Clinical Virology

Organizing Committee - Retroviruses-2015

Biography

Dr. Lindsay Hughes is a behavioral scientist with 10 years of progressive experience in research, design, proposal development, and implementation of evidence-based health science studies and interventions using effective, strategic, and culturally sensitive human communication and information technologies to improve health outcomes through increased access and adherence to medical interventions. She has developed various models to measure patient outcomes at the individual, dyadic, and community levels, and has designed innovative dissemination and data capture tools using eHealth and mHealth platforms.

Research Interest

Dr. Hughes has extensive experience managing concurrent diverse, multi-faceted domestic and international OR portfolios in various capacities (including PI, AI, and Advisor); partnering with clinical and laboratory scientists; and capacity building and mentorship of junior staff and scientists as well as local and indigenous organizations to improve scientific acumen, and leverage resources to develop strategic partnerships with governments, ministries, and private-sector partners. She has worked with various funders (e.g., USAID, CIDA, CDC, NIH, DOD, WRAIR, BMGF, HRA Pharma) and has a track record of developing, facilitating, and improving relationships with clients and stakeholders. She is skilled at quantitative and qualitative methods; regulatory strategy design; scientific, consulting, and technical writing; and translation of data for diverse audiences.

Biography

Research Interest

Biography

Karin Moelling was born in Northern Germany, trained as a physicist specialized in Nuclear Physics. She was trained at Berkeley, University of California, in Molecular Biology and Biochemistry. She took her PhD at the Max-Planck-Institute for Virology at Tübingen, Germany, and her Habilitation at the University of Giessen in Biophysics. She worked at the Robert Koch-Institute in Berlin, the Max-Planck-Institute for Molecular Genetics in Berlin. In 1993 she became Director and Professor of the Institute for Medical Virology at the University of Zurich and Head of the Viral Diagnostics Department of the University Hospital, which she increased 15-fold. She had to retire there and is still affiliated with the University of Zurich and the Max-Planck-Institute for Molecular Genetics in Berlin. She was Fellow at the Institute of Advanced Study at Berlin 2008/2009 and became Vice President of the Fellow Club.

Biography

Specialty: Viral Oncology
Awards
Research Career Award
National Research Council of Argentina
Damon Runyon Fund Fellowship
Member
National Academy of Medicine, Argentina
Outstanding Women in Science Award
AWIS Metropolitan N.Y
Fellow
New York Academy of Sciences
Membership
Sigma Xi, The Scientific Research Society

Research Interest

The main research of this laboratory concerns molecular mechanisms of viral pathogenesis.
Fifteen percent of human cancers are associated with or caused by viruses. We are investigating if a virus similar to the mouse mammary tumor virus (MMTV) is involved in human breast cancer pathogenesis. We have found viral sequences similar to MMTV in 38% of the human breast cancers tested. They were expressed as RNA and proteins. A complete proviral structure has been detected with the characteristics of a replicative competent virus.
Recently, we isolated and characterized a beta retrovirus from primary cultures of human breast cancer cells. The retrovirus is able to infect epithelial and lymphocytic human cells. Its potential for malignant transformation is being investigated. Epidemiological studies on breast cancer and retroviral incidence are also carried out by analyzing samples from different geographical locations. The transcriptional profile of breast cancer cells carrying the virus was also investigated. Together, these studies will help to determine if a retrovirus is involved in human breast cancer pathogenesis.

Biography

Dr. Shan Cen is a Professor and Head of Immunology Division at the Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Pekin Union Medical College, China, Project director, Lady Davis Institute for Medical Research, Jewish General Hospital Canada, Adjunct Assistant Professor Department of Microbiology, McGill University, Canada, Adjunct Faculty member Department of Medicine McGill University, Canada. He received his PhD degree in Microbiology from Chinese Academy of Preventive Medicine in 1994. He has completed his MS in Microbiological Medicine, Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, China, and he has also completed BSc from the Department of Microbiology, Shandong University, China. Dr Shan Cen has been serving as a reviewer for reputed journals including J Biol Chem J Virol PlosOne Virology Retrovirology for years.

Biography

Dr. Mansky is Professor and Director of the Institute for Molecular Virology, University of Minnesota. He received his PhD degree in Molecular Virology from Iowa State University and was a postdoctoral fellow in the laboratory of Dr. Howard Temin at the McArdle Laboratory for Cancer Research, University of Wisconsin-Madison.

Organizing Committee - Retroviruses 2016

Biography

Enzo Tramontano holds a degree from the University of Cagliari (1990), he was Visiting Research Scientist at the Dept. of Pharmacology at Yale University Medical School (CT, USA, 1990-1992 and 1996-1998). He was given two post-doctoral awards granted by the Istituto Superiore di Sanità for “Research in the HIV field: AIDS Project”, for research activities performed in national (1993-1995) and international (1996-1998) institutions. Since 1998 he has worked at the Departments of Experimental Biology (1998-2003), Biomedical Sciences and Technologies (2003-2007), Applied Sciences in Biosystems (2007-2010) and Life and Environmental Sciences (2011-2012) at the University of Cagliari being appointed as Research Associate (1998), Assistant Professor (2001), and Associate Professor (2006). He is now responsible for the Biomedical Section of the Department of Life and Environmental Sciences of the University of Cagliari. He is member of the European Society of Virology, the International Society for Antiviral Research, the Italian Society of Virology and the Italian Society of General Microbiology and Microbial Biotechnologies. Prof. Tramontano serves as ad hoc reviewer for several International Journals and the Italian Minister of Research.

Research Interest

Biography

Dr. Barr obtained his PhD in Molecular Biology from the University of Calgary, studying a family of antioxidant proteins called Peroxiredoxins in the tropical parasite called Leishmania. His research provided a better understanding of how intracellular pathogens such as Leishmania survive inside of macrophages, which are the cells normally designed to kill these pathogens. After his PhD, Dr. Barr traveled to Philadelphia as a Postdoctoral Fellow to work with Dr. Rick Bushman at The University of Pennsylvania. There he studied the molecular interactions between the human immunodeficiency virus (HIV) and host cellular genomes. His research provided a better understanding of how HIV permantently integrates into the genome of its host cells; a process that contributes to life-long infection. Near the end of his time with Dr. Bushman, he discovered a novel human protein called TRIM22 that inhibits HIV replication by trapping the virus inside of cells. He took this project to the laboratory of Dr. Smiley at the University of Alberta to utilize the expertise of Dr. Jim Smiley to better understand the mechanism of how TRIM22 traps HIV inside of cells. Near the end of his time in Dr. Smiley’s laboratory he discovered another novel human protein called HERC5 that also inhibited HIV replication. Dr. Barr took this project to Western as an independent investigator where his team unlocked the novel mechanisms by which this interesting protein blocks HIV replication.
Currently, Dr. Barr is a molecular virologist at Western in the department of Microbiology and Immunology where his team continues to unlock the mysteries of TRIM22, HERC5 and HIV. It is their goal to exploit the powerful and natural activities of HERC5 and TRIM22 to help block HIV replication and allow our immune system to get the upperhand in clearing HIV infection. Dr.
Barr’s team also recently discovered an exciting new way that HIV integrates into the human genome. This research hopes to uncover a neverbefore seen mechanism of how HIV establishes and maintains latency, which is one of the biggest obstacles in curing HIV/AIDS. Their work also has potential implications in the design of next-generation retroviral-based gene therapy vectors.

Research Interest

Biography

The Gabonese researcher, Donatien Mavoungou, is about to discover the first vaccine against the AIDS virus. The professor in chemistry worked out IMMUNOREX TM which test results are rather promising for the moment.
During his passage on 16th June 2014 in Libreville (Gabon), Pr Donatien Mavoungou and his colleagues presented to the Gabonese press, IMMUNOREX TM, the treatment that could become the vaccine against the HIV / AIDS. According to the Gabonese quoted by the site Gabonreview, the vaccine is tested at its second phase and was already tested on 200 sick people in France without any negative reaction registered.
“We have at present a therapeutic vaccine against AIDS, which is till today, one of the rare in the world to have succeeded to enter into the 2nd phase with an authorization of stopping the triple agent therapy for two months“, declared Pr Mavoungou.
The Gabonese researcher is supported in his works by the managing director of the international institute for developement and the support innovative scientific research, Michel Paul Correa. For the latter, “involving Gabon via Immunorex of Pr Donatien Mavoungou in the development of a vaccine against AIDS with Biosantech is an important challenge in all respects for the influence of Gabon.”
Africa is the continent the most affected by the HIV / AIDS. In 2005 UNAIDS registered 1,8 million deaths caused by the virus on the continent.

Research Interest

Biography

Eddy Arnold is Board of Governors Professor of Chemistry and Chemical Biology at Rutgers University and a Resident Faculty Member at the Center for Advanced Biotechnology and Medicine. He has authored more the 240 scientific publications. Among his awards and honors are two NIH MERIT Awards (1998-2008, 2009-2019) and the Hyacinth Award “Honoring Advances in the Struggle Against AIDS” (2013). He is an elected Fellow of the American Association for the Advancement of Science (2001) and in the American Academy of Microbiology (2006).

Research Interest

Biography

Ekwu B. B. Ochigbo is a Registered Pharmacist and an HIV & AIDS resource person. He holds an M. Phil. with distinction in HIV & AIDS Management from the Africa Centre for HIV & AIDS Management, Stellenbosch University, Cape Town, South Africa. He is also the Director of Tibe Pharmacare, a pharmaceutical and health research consultancy close corporation. His interests are in therapeutics and treatment outcomes research.
Ochigbo has participated in different clinical research including the pharmacokinetics study for Boehringer Ingelheim- 1100.1518, an open-label, multiple dose, cross-over study to evaluate the steady-state pharmacokinetic parameters of Nevirapine extended release tablets in HIV-1 infected children, leading to the successful registration of Nevirapine XR by the USA FDA in March 2011. He was also Principal Investigator for the study of the Adherence to prevention of mother to child transmission (PMTCT) therapy among HIV infected pregnant women in Area W Clinic, Botswana.
Ochigbo is a member of the Pharmaceutical Society of Nigeria, the Pharmaceutical Society of Botswana, and the Pharmaceutical Society of Namibia. He is also a member of the Rotary club of Francistown.

Research Interest

Biography

Vladimir Zajac has completed his Ph.D. in 1982 at the Cancer Research Institute of Slovak Academy of Sciences in Bratislava (Slovakia), where he was from 1996 to 2010 the Head of Department of Cancer Genetics. He joined the Medical Faculty of the Comenius University as Associate Professor of Genetics in 2007. He has published 56 papers mostly in reputed journals and he was editor of the book "Bacteria, viruses and parasites in AIDS process" (InTech)

Research Interest

Cancer and AIDS

Organizing Committee - Retroviruses 2017

Biography

Edgar Marcelino de Carvalho Filho was born in Salvador, Bahia, on May 24, 1950. His parents, Edgar Marcelino de Carvalho and Valdemira Silva de Carvalho, were teachers, had teaching activities and were an example and a stimulus for the son. The secondary course was held at the Colégio AplicÃo of the Federal University of Bahia, one of the best schools in Salvador and recognized as a teacher of student leaders. The interest in medicine and teaching comes from childhood and adolescence and interest in research during the medical course at the Faculty of Medicine of the Federal University of Bahia. APSA graduation in 1973 made residence and Masters in Internal Medicine and in 1977 held fellowship in the area of Immunology and Rheumatology at the University of Virginia. The Master's thesis entitled "Patients with Bacteremia in severe strongyloidase The importance of the worm as a vehicle or synergistic agent of bacterial infection" was guided by Professor Heonir Rocha, a researcher who also directed several scientific works At the beginning of the career.
The training in Immunology at the University of Virginia was conducted with Dr. David Horowitz, having been useful in relation to the learning of immunology techniques as a proficiency in scientific productivity stay. In this period they were published three manuscripts in J. Immunol. and in Clin. Exp. Immunol. . Immunology did not yet exist in Bahia when he returned in 1979, when he created the Research Laboratory in Immunology, which later was elevated to the category of Immunology Service. It was at this time that interest in leishmaniasis began, which together with schistosomiasis and strongyloidase constitute the main lines of research of the Immunology Service.
He defended his doctorate in 1986 with the thesis "Cellular Immunity in Visceral Leishmaniasis", on which occasion he became an Adjunct Professor of the Faculty of Medicine of the Federal University of Bahia. He coordinated for four years the P s-Graduation course in Internal Medicine of the Federal University of Bahia and coordinates until the moment (2002) the activities of masters and doctorate in the area of Clinical Immunology. J directed 17 master's theses and 8 doctoral theses and at the moment 2 master's degrees and 7 doctoral students are under his guidance. The main lines of research are the Immunology of Visceral and Intestinal Leishmaniasis, Immunotherapy in Infectious Diseases, Immunoregulation in Mansonic Schistosomiasis and Clinical and Immunological Aspects of the Association between HTLV-1 and Strongyloidase. J was a member of the editorial board of the Brazilian Journal of Medicine and Biological Research and Associate Editor of the Journal of the Brazilian Society of Tropical Medicine. member of the Brazilian Society of Immunology, organ presided between 1989 and 1991, the American Association of immunologists , the Brazilian Society of Tropical Medicine and the American Journal of Tropical Medicine and Hygiene .

Research Interest

Immunology of tegumentary leishmaniasis.
Clinical and therapeutic aspects of tegumentary leishmaniasis.
Natural history and immune response in HTLV-1 infection.
Association between HTLV-1 infection and helminthiasis.
Immunomodulation in schistosomiasis.

Biography

Harold C. Smith, Ph.D. is a cell and molecular biologist and tenured full professor in the Department of Biochemistry and Biophysics at the University of Rochester, School of Medicine and Dentistry. As a member of the faculty, Dr. Smith developed and instructs the primary technical training course for undergraduates in the Biochemistry major and runs a research laboratory from which over 130 pier reviewed publications have emerged on biological control mechanisms affecting diseases such as cancer, elevated cholesterol and heart disease and HIV/AIDS. He has led his research field with federal and foundation funding and is a key opinion leader on APOBEC host defense factors. In 2003, Dr. Smith founded OyaGen, Inc based on ground breaking research revealing our innate ability to ward off an infection by HIV for the purpose of developing a novel drug intervention strategy towards an eventual cure for AIDS. His biotech company has unique technology and equipment that has enabled recognition of the Company by Federal, State and the pharmaceutical industry as having taken innovation to a new level with promising achievements that are of great importance and potential to the healthcare industry. OyaGen is located at 77 Ridgeland Rd in Henrietta NY, USA. For more information on Dr. Smith and OyaGen please visit the following webpages:
http://en.wikipedia.org/wiki/Harold_Smith_(scientist)
http://www.oyageninc.com

Research Interest

Dr. Smith founded OyaGen, Inc based on ground breaking research revealing our innate ability to ward off an infection by HIV for the purpose of developing a novel drug intervention strategy towards an eventual cure for AIDS. His biotech company has unique technology and equipment that has enabled recognition of the Company by Federal, State and the pharmaceutical industry as having taken innovation to a new level with promising achievements that are of great importance and potential to the healthcare industry.

Biography

Dr. Julius Nwobegahay was born in Cameroon. He Obtained a Bsc (Hons) Microbiology degree at the University of Calabar, Nigeria; a Masters degree in Virology at the University of Ibadan, Nigeria; and a Doctoral degree (topic: ‘Human Immunodeficiency Virus Genetic Drug Resistance and Subtype Distribution in Northern South Africa’) from the University of Venda, South Africa.
He has authored and co-authored many scientific publications in peer reviewed accredited national and international journals, and have presented papers at international conferences in South Africa and Europe. He is also a reviewer for many scientific journals, and has mentored and supervised many graduate students.
He is presently the head of the Military Health Research Center (CRESAR) in Cameroon. Dr. Nwobegahay’s laboratory is actively involved in research on military medical research ethics and guidelines, human subject research with military populations, HIV drug resistance, Hepatitis B and C viruses. Furthermore, CRESAR is collaborating with its main partner - Metabiota Cameroon to roll out programs within the Cameroon military on HIV/AIDS prevention; reinforcement of prevention of mother-to-child transmission (PMTCT) of HIV; boosting the laboratory capacities of Cameroon military health formations; rapid detection, response and research on avian influenza, monkey pox virus, etc.

Research Interest

Organizing Committee - Virology Asia 2017

Biography

Dr. PR Raghavan is the CEO and Founder of Nanorx Inc in New York, USA. He has a Ph.D. in Organic Chemistry from Oregon State University (1979) and a M.S. in Chemistry (1972) from I.I.T. Mumbai, India. He has worked on drug discovery for over 25 years at Columbia University, Max-Planck Institute, Germany, Ciba-Geigy (now Novartis) and Boehringer Ingelheim. He has over 12 approved patents and another 15 pending patent applications

Research Interest

He has worked on drug discovery for over 25 years at Columbia University, Max-Planck Institute, Germany, Ciba-Geigy (now Novartis) and Boehringer Ingelheim.

Biography

Peter Timms obtained his PhD in molecular microbiology from the University of Queensland, Australia in 1989. After 20+ years working at QUT (Brisbane) he moved to the University of the Sunshine Coast, in 2014 where he is Professor of Microbiology. He has spent over 25 years working on all aspects of Chlamydia, in humans and animals (koalas). His team has made major discoveries in chlamydial genomics, evolution, vaccine development and basic mechanisms of pathogenesis. He has published over 240 papers

Research Interest

He leads a well established research team of 10 people. His research group is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas.

Biography

Dr Amita Jain is a multifaceted medical teacher who has contributed immensely in the field of microbiology. She has worked in many areas of medical microbiology including Tuberculosis, Bacteriology and virology. She is a keen researcher and has successfully completed many research and public health projects and published several papers, some of which are highly cited. She has guided 24 PhD students and have provided guidance to many undergraduate and postgraduate students. She has established new diagnostic and research facilities, which are of immense help to medical students, researchers and patients. She has investigated several epidemics of swine flu, dengue, Acute encephalitis, hepatitis, drug resistant TB etc. She has provided diagnostic services to Uttar Pradesh state health services in the field of virology and tuberculosis. She has organized trainings for laboratorians and community awareness health programs.

Research Interest

She is expert in the field of medical microbiology including Tuberculosis, Bacteriology and virology.

Biography

Dr. Rajarshi Kumar Gaur is presently working as Associate Professor& Head, Department of Bioscience, Mody University of Science and Technology, Lakshmangarh, Sikar, Rajasthan. He did his Ph.D on molecular characterization of sugarcane viruses of India. He partially characterized three sugarcane virus viz., sugarcane mosaic virus, sugarcane streak mosaic virus and sugarcane yellow luteovirus. He received MASHAV fellowship in 2004 of Israel government for his post-doctoral studies and joined The Volcani Centre, Israel and then shifted to Ben Gurion University, Negev, Israel. In 2007 he received the Visiting Scientist Fellowship from Swedish Institute Fellowship, Sweden for one year to work in the The Umeå University, Umeå, Sweden. He is also a recipient of ICGEB, Italy Post-Doctoral fellowship in 2008. He worked on development of marker-free transgenic plant against cucumber viruses. He has made significant contributions on plant viruses and published 120national/international papers and presented near about 50 papers in the national and international conferences. Presently, he is working on the characterization of begomovirus and development of resistance plant by using RNAi technolongy.

Research Interest

Presently, he is working on the characterization of begomovirus and development of resistance plant by using RNAi technolongy.

Biography

Dr. Zhaocai Zhou obtained his Ph.D. degree in University of Science and Technology of China, 2004; and received his postdoctoral training in Brandeis University, and University of Pennsylvania, USA, 2004–2008. He joined the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences in 2009, and become a professor of Shanghai Tech University in 2015. His primary research interest is to understand the signaling mechanism of tumorigenesis and tumor-related immune regulation. His recent work focuses on Hippo/MST signaling pathway and macrophage plasticity.

Research Interest

Our primary research interest is to understand the principle of immune responses and tumor immunology at multiple levels (Figure 1). We combine biochemical and structural analyses with cell signaling, animal models and clinical relevance to explore the function and molecular mechanisms of protein/DNA complexes and pathways that are critical for both immunity and tumorigenesis (Figure 2). In addition to dissecting the nature of these fundamental physiological or pathological processes, we also aim to further discover new drug targets and design novel therapeutic strategies for disease treatment.

Biography

Naeima M.H. Yousef has completed her Ph.D from Bielefeld University, Germany and postdoctoral from Botanik Institute, Germany and Botany Department, Faculty of Science, Assiut University, Egypt. She was the head of Botany Department New Valley branch, Faculty of Science, Assiut University. She is associate Prof. of Microbiology Botany Department, Faculty of Science, Assiut University, Egypt. She published more than 20 papers in reputed journals and international conferences.

Research Interest

Study the antimicrobial activity of metal nanoparticles against some pathogenic microbes.

Biography

Dr. Kim Van Van is Head of Aquatic Environment & Diseased Department Vice Dean of Fisheries Faculty in Vietnamese National University of Agriculture (VNUA). He graduated with a B.Sc. in Veterinary on Microbiology in 1994 and with a MSc. in Microbiology in 1999 on Aquaculture Diseases in Stirling Scotland and PhD in Veterinary on Biotechnology in 2014 between Denmark and Vietnamese.

Research Interest

His main research interests are in aquatic animal health & disease organisms.

Biography

Pham Hong Ngan has his expertise in virology and public health. He was estaplished the department of Veterinary Public Health. He has great contribution for the development of the Veterinary Faculty as well as Vietnam National University of Agriculture. For students he is respected teacher with extensive knowledge. For the staff he is excellent leader.

Be a member and support us

Follow us

Authorization Policy

By registering for the conference you grant permission to Conferenceseries Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.